D. M. Parkin, . Bray, &. Ferlay, and . Pisani, Global cancer statistics, vol.55, pp.74-108, 2002.

S. R. Wellings and H. M. Jensen, On the origin and progression of ductal carcinoma in the human breast, JNatl Cancer Inst, vol.50, pp.1111-1118, 1973.

S. Krishnamurthy and . Sneige, Molecular and biologic markers of premalignant lesions of human breast, Adv Anat Pathol, vol.9, pp.185-197, 2002.

E. Schmidt, V: Genes involved in breast cancer progression: analysis of global changes in gene expression or retroviral tagging?, Am J Pathol, vol.161, 1973.

C. Garnis, T. P. Buys-&-w, and . Lam, Genetic alteration and gene expression modulation during cancer progression, Mol Cancer, vol.3, p.9, 2004.

F. Hube, . Mutawe, &. Leygue, and . Myal, Human small breast epithelial mucin: the promise of a new breast tumor biomarker, DNA Cell Biol, vol.23, pp.842-849, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02127366

R. L. Houghton, D. C. Dillon, D. A. Molesh, and B. ,

J. Zehentner, . Xu, C. Jiang, . Schmidt, . Frudakis et al., Transcriptional complementarity in breast cancer: application to detection of circulating tumor cells, Mol Diagn, vol.6, pp.79-91, 2001.

R. J. Miksicek, Y. Myal, P. H. Watson, and L. Walker,

&. Murphy and . Leygue, Identification of a novel breast-and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium, Cancer Res, vol.62, pp.2736-2740, 2002.

T. L. Colpitts, . Billing, M. Granados, and . Hayden,

. Hodges, J. Roberts, P. Russell, . Friedman, and . Stroupe, Identification and immunohistochemical characterization of a mucin-like glycoprotein expressed in early stage breast carcinoma, Tumour Biol, vol.23, pp.263-278, 2002.

K. Quandt, K. Frech, H. Karas, &. T. Wingender, and . Werner, MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data, Nucleic Acids Res, vol.23, pp.4878-4884, 1995.

E. Wingender, X. Chen, X. , E. Fricke, R. Geffers et al., The TRANSFAC system on gene expression regulation, vol.29, pp.281-283, 2001.

F. Hube, P. Reverdiau, S. Iochmann, C. Cherpi-antar, and &. Y. Gruel, Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line, Thromb Res, vol.109, pp.207-215, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02127781

M. Tanaka and &. W. Herr, Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation, vol.60, pp.375-386, 1990.

C. O. Brown, X. Iii, E. Chi, M. Garcia-gras, X. H. Shirai et al., The cardiac determination factor, Nkx2-5, is activated by mutual cofactors GATA-4 and Smad1/4 via a novel upstream enhancer, J Biol Chem, vol.279, pp.10659-10669, 2004.

M. A. Su and . Anderson, Aire: an update, Curr. Opin. Immunol, vol.16, pp.746-752, 2004.

M. Gstaiger, L. Knoepfel, O. Georgiev, and W. &. Schaffner, Hovens: A B-cell coactivator of octamer-binding transcription factors, Nature, vol.373, pp.360-362, 1995.

H. Chen and &. S. Sukumar, Role of homeobox genes in normal mammary gland development and breast tumorigenesis, J Mammary Gland Biol Neoplasia, vol.8, pp.159-175, 2003.

R. A. Sturm, G. Das, and &. Herr, The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain, Genes Dev, vol.2, pp.1582-1599, 1988.

D. S. Latchman, The Oct-2 transcription factor, Int. J. Biochem. Cell Biol, vol.28, pp.1081-1083, 1996.

T. Jin, D. R. Branch, X. Zhang, S. Qi, B. &. Youngson et al., Examination of POU homeobox gene expression in human breast cancer cells, Int J Cancer, vol.81, pp.104-112, 1999.

J. W. Voss, L. G. Wilson-&-m, and . Rosenfeld, POU-domain proteins Pit-1 and Oct-1 interact to form a heteromeric complex and can cooperate to induce expression of the prolactin promoter, Genes Dev, vol.5, pp.1309-1320, 1991.

F. Q. Zhao, K. Adachi, &. T. Oka-;-boulon, S. , J. C. Dantonel et al., Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB-and CREB binding protein-independent mechanism, Biochim Biophys Acta, vol.1577, pp.7769-7779, 2002.

L. Cicatiello, R. Addeo, A. Sasso, L. Altucci, V. B. Petrizzi et al., Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter, Mol Cell Biol, vol.24, pp.7260-7274, 2004.

M. Kim, . O. H-&-d, and . Peterson, Stimulation of basal transcription from the mouse mammary tumor virus promoter by Oct proteins, J Virol, vol.69, pp.4717-4726, 1995.

M. K. Kim, L. A. Lesoon-wood, B. D. Weintraub, and &. H. Chung, A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine-rich domain, Mol Cell Biol, vol.16, pp.4366-4377, 1996.

F. Hube, Y. Myal, and &. E. Leygue, The promoter competition assay (PCA): a new approach to identify motifs involved in the transcriptional activity of reporter genes, Front Biosci, vol.11, pp.1577-1584, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02127345

D. K. , H. M. Zheng, Z. Y. Wen-&-z, and . Chen, The POU homeodomain protein Oct-1 binds Cis-regulatory element essential for the human GnRH upstream promoter activity in JEG-3 cells, J Clin Endocrinol Metab, vol.86, pp.2838-2844, 2001.

G. G. Prefontaine, R. Walther, W. Giffin, M. E. Lemieux, L. J. Pope-&-r et al., Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter, J Biol Chem, vol.274, pp.26713-26719, 1999.

M. M. Gonzalez and . Carlberg, Cross-repression, a functional consequence of the physical interaction of nonliganded nuclear receptors and POU domain transcription factors, J Biol Chem, vol.277, pp.18501-18509, 2002.

S. Belikov, C. Astrand, P. H. Holmqvist, and &. Wrange, Chromatin-mediated restriction of nuclear factor 1/CTF binding in a repressed and hormone-activated promoter in vivo, Mol Cell Biol, vol.24, pp.3036-3047, 2004.

C. Fletcher, N. Heintz, and &. R. , Roeder: Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene, Cell, vol.51, pp.773-781, 1987.

C. S. Malone, L. Patrone, and &. R. Wall, An essential octamer motif in the mb-1 (Igalpha) promoter, Mol Immunol, vol.37, pp.321-328, 2000.

S. Inamoto, N. Segil, Z. Q. Pan, M. G. Kimura-&-r, and . Roeder, The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors, J Biol Chem, vol.272, pp.29852-29858, 1997.

Y. Luo, H. Ge, S. Stevens, H. G. Xiao-&-r, and . Roeder, Coactivation by OCA-B: definition of critical regions and synergism with general cofactors, Mol Cell Biol, vol.18, pp.3803-3810, 1998.

C. Malone and . S-&-r-wall, Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters, J Immunol, vol.168, pp.3369-3375, 2002.

K. Lins, A. Remenyi, A. Tomilin, S. Massa, M. Wilmanns et al., Scholer: OBF1 enhances transcriptional potential of Oct1, EMBO J, vol.22, pp.2188-2198, 2003.

C. K. Inman, N. Li, and &. P. Shore, Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein, Mol. Cell Biol, vol.25, pp.3182-3193, 2005.

, Komori T: Runx2, a multifunctional transcription factor in skeletal development, J Cell Biochem, vol.87, pp.1-8, 2002.

G. L. Barnes, A. Javed, S. M. Waller, M. H. Kamal, and K. E. ,

M. Q. Hebert, A. Hassan, A. J. Bellahcene, M. F. Van-wijnen, J. B. Young et al., Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells, Cancer Res, vol.63, pp.2631-2637, 2003.